| answer text |
<p>The Department fully understands that maintaining access to hormone replacement
therapy (HRT) medications is vitally important to many people in this country.</p><p>We
are aware of ongoing supply issues with some HRT preparations due to manufacturing
issues. We have been working closely with all suppliers of HRT preparations to maintain
overall supply to patients.</p><p>We continue to work with all stakeholders to ensure
relevant information about the HRT products affected by supply issues and the products
that remain available is shared across the National Health Service on a regular basis.</p><p>
</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p>
|
 |
